Pilot study: Evaluation of potential drug–drug interactions in hospitalized pediatric patients by Fabiola Medina-Barajas, Estefanía Vázquez-Méndez, Edsaúl Emilio Pérez-Guerrero, Virginia Aleyda Sánchez-López, Iván I. Hernández-Cañaveral, Real-Ornelas Gabriel A, Selene G. Huerta-Olvera

Subjects: “…drug-drug interactions…”
Get full text

Managing ciprofloxacin-clozapine interaction with immunoassay-based monitoring: A case report by Kristin Waters, PharmD, BCPS, BCPP, Victoria Popielarz, BS, PharmD Candidate, Joseph Lumasag, BS, PharmD Candidate, Sara Wiesenfeld, BS, PharmD Candidate, Ashley Tewksbury, PharmD, BCPP

Subjects: Get full text

Practical aspects of apixaban use in clinical practice: continuing the theme by S. N. Bel'diev

Subjects: Get full text

Evaluation of the Drug–Drug Interaction Potential of the GlyT1 Inhibitor Iclepertin (BI 425809): A Physiologically Based Pharmacokinetic (PBPK) Modeling Approach by Elin M. Matsson, Michael Desch, Valerie Nock, Nina Hanke

Subjects: “…drug–drug interactions…”
Get full text

A TYPICAL PATIENT WITH HIV TODAY: COMPREHENSIVE CHARACTERIZATION AND ANTIRETROVIRAL TREATMENT OPTIONS (BASED ON DATA OF THE ST. PETERSBURG AIDS CENTER) by D. A. Gusev, N. V. Sizova, S. O. Mayorova, V. V. Bratkova, A. L. Sotnikova, T. V. Malkova

Subjects: Get full text

Chinese population may require further venetoclax dose reduction beyond guidelines when combined with voriconazole: real-world evidence from China by Rongrong Wang, Yanfen Li, Ran Zhang, Yuan Ren, Yifan Liu, Tianlin Wang, Jin Wu, Xiangjin Zheng, Shu Li, Yu Jing

Subjects: Get full text

Genome-wide associations spanning 194 in-hospital drug dosage change phenotypes highlight diverse genetic backgrounds in concurrent drug therapy by Alexander Pil Henriksen, Cristina Leal Rodríguez, Hannah Currant, Ioannis Louloudis, Jorge Hernansanz Biel, Maria Herrero-Zazo, Ewan Birney, Thomas Folkmann Hansen, Gianluca Mazzoni, Amalie Dahl Haue, Henning Bundgaard, Christian Erikstrup, Khoa Manh Dinh, Liam Quinn, Mie Topholm Bruun, Henrik Hjalgrim, Erik Sørensen, Christina Mikkelsen, Michael Schwinn, Ole Birger Vestager Pedersen, Henrik Ullum, Sisse Rye Ostrowski, Karina Banasik, Søren Brunak

Subjects: Get full text

Potential Drug Interactions in Hospitalized Hematologic Cancer Patients: New Update with New Chemotherapy Regimens by Tahereh Gholipourshahraki, Amir Aria, Mehran Sharifi, Ayda Moghadas, Azadeh Moghaddas

Subjects: Get full text

Predicting inhibitors of OATP1B1 via heterogeneous OATP-ligand interaction graph neural network (HOLIgraph) by Mehrsa Mardikoraem, Joelle N. Eaves, Theodore Belecciu, Nathaniel Pascual, Alexander Aljets, Bruno Hagenbuch, Erik M. Shapiro, Benjamin J. Orlando, Daniel R. Woldring

Subjects: Get full text

The Problem of Drug Interactions Between Rosuvastatin and Ticagrelor in the Aspect of the Risk of Rhabdomyolysis: Discussion of the Problem and Description of the Clinical Case by O. V. Gaisenok, Yu. M. Chichkov, M. V. Leonova

Subjects: Get full text

ASSESSING STROKE PATIENTS' TREATMENT AND PROGNOSIS TO ENHANCE THERAPEUTIC STRATEGIES by Nadeem Ullah Khan Wazir, Asad Ur Rahman, Rizwan Amir Khan, Irfan Amir Khan, Ihsan Ullah Wazir, Noman Ullah Wazir, Muhammad Aftab Wazir, Tawseef Ahmad

Subjects: Get full text

Interaction of rivaroxaban with amiodarone, verapamil and diltiazem in patients with atrial fibrillation: terra incognita by S. N. Bel'diev

Subjects: “…rivaroxaban, amiodarone, verapamil, diltiazem, drug-drug interactions, atrial fibrillation…”
Get full text

Osmotic laxatives do not alter dabigatran plasma concentration in healthy volunteers – a randomized, controlled, cross-over trial by Matthias Weiss-Tessbach, Al Medina Dizdarevic, Alexander Kupis, Thorsten Bischof, Christa Firbas, Peter Quehenberger, Ulla Derhaschnig, Max Frimmel, Bernd Jilma, Christian Schoergenhofer

Subjects: Get full text

Influence of N-Acetyl-L-Cysteine on the Pharmacokinetics and Antibacterial Activity of Marbofloxacin in Chickens by Albena Roydeva, Nikolina Rusenova, Aneliya Milanova

Subjects: Get full text

Drug-drug interactions in hospitalized older adults with acute coronary syndrome – a real-world study in Brazil by Tiago Aparecido Maschio de Lima, Moacir Fernandes de Godoy

Subjects: Get full text

Decrease in Efficacy of Warfarin as a Result of Drug-Drug Interaction (Case Report) by N. T. Vatutin, G. G. Taradin, G. A. Ignatenko, E. S. Gasendich, A. V. Harchenko, I. B. Povaljaeva

Subjects: Get full text

Comparison and analysis of 4 drug interaction databases in nephrology patients using clinical pharmacy approaches: A crosssectional study by Eren Demirpolat, Nisa Güneş

Subjects: Get full text

Reveal the potent antidepressant effects of Zhi-Zi-Hou-Pu Decoction based on integrated network pharmacology and DDI analysis by deep learning by Zhiwen Zhang, Xiaojing Li, Zihui Huang, Zhenxing Pan, Lingjie Li, Yang Wang, Siwei Wu, Yan Xing, Guanlin Xiao, Yan He, Dake Cai, Xujie Liu

Subjects: Get full text

Evaluating Major Bleeding Risks with Concomitant Use of Direct Oral Anticoagulants and Selective Serotonin Reuptake Inhibitors in Nonvalvular Atrial Fibrillation Patients by Shu-Yu Yao, Paul T. Kocis, Terrence E. Murphy, Wenke Hwang

Subjects: Get full text

Prevalence and factors associated with potential clinically significant drug-drug interactions in patients with cardiovascular diseases at hospital admission by Marović Iva, Udovičić Mario, Rudan Diana, Manola Šime, Samardžić Ivana, Vrca Vesna Bačić, Hadžiabdić Maja Ortner, Marinović Ivana

Subjects: Get full text